Publication | Closed Access

Metallothionein protects against doxorubicin-induced cardiomyopathy through inhibition of superoxide generation and related nitrosative impairment

CardiomyopathyHeart FailureSuperoxide GenerationRelated Nitrosative ImpairmentCardiovascular DiseasePhysiologyPharmacologyDoxorubicin-induced CardiomyopathyPharmacotherapyCardiovascular ToxicityMedicineCardiologyOxidative Stress